Patient-level micro-simulation model for evaluating the future potential cost–effectiveness of pharmacy-based interventions in the control and management of diabetes-related complications in Canada

Mohsen Yaghoubi, Kerry Mansell, Hassanali Vatanparast, Wu Zeng, Mehdi Javanbakht, Marwa Farag
doi: https://doi.org/10.1101/2020.03.10.20033597

Article Information

doi 
https://doi.org/10.1101/2020.03.10.20033597
History 
  • March 13, 2020.
Copyright 
The copyright holder has placed this preprint in the Public Domain. It is no longer restricted by copyright. Anyone can legally share, reuse, remix, or adapt this material for any purpose without crediting the original authors.

Author Information

  1. Mohsen Yaghoubi1,*,
  2. Kerry Mansell2,
  3. Hassanali Vatanparast1,
  4. Wu Zeng3,
  5. Mehdi Javanbakht4 and
  6. Marwa Farag1
  1. 1School of public health, University of Saskatchewan, Saskatoon, Canada
  2. 2College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Canada
  3. 3Department of International Health, School of Nursing & Health Studies, Georgetown University
  4. 4Device Access UK Ltd
  1. ↵*Mohsen Yaghoubi (Corresponding author)
    School of public health, University of Saskatchewan, Saskatoon, Canada, University of Saskatchewan, Health Sciences Building, Room E2249, 104 Clinic Place, Saskatoon, SK S7N 5E5, Phone (306)491-3470, email: mohsen.yaghoubi{at}ubc.ca
Back to top
Posted March 13, 2020.
Download PDF
Data/Code
Email
Patient-level micro-simulation model for evaluating the future potential cost–effectiveness of pharmacy-based interventions in the control and management of diabetes-related complications in Canada
Mohsen Yaghoubi, Kerry Mansell, Hassanali Vatanparast, Wu Zeng, Mehdi Javanbakht, Marwa Farag
medRxiv 2020.03.10.20033597; doi: https://doi.org/10.1101/2020.03.10.20033597
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area